Jon Cuthbert - Author on Grafa
All
Bausch Health liver drug fails to meet main goal in Phase 3 trial
Bausch Health Companies (NYSE:BHC) today announced results from its global Phase 3 RED-C clinical program evaluating amorphous-rifaximin SSD for the primary prevention of hepatic encephalopathy (HE) in adults with liver cirrhosis.
SLB posts Q4 revenue of $9.75 billion, up 9% sequentially
SLB (NYSE:SLB) today reported financial results for the fourth quarter and full year ended December 31, 2025, reflecting sequential improvement driven by international activity and offshore growth despite softer year-over-year comparisons.
China deepens probe into Meta’s $2B acquisition of AI startup Manus
Beijing has intensified its scrutiny of Meta Platforms (NASDAQ:META) $2 billion acquisition of Chinese-founded agentic AI startup Manus, expanding the probe beyond initial concerns over technology export and national security rules to include potential violations of cross-border currency controls, tax accounting standards, and overseas investment regulations, according to people familiar with the matter.










